Rankings
▼
Calendar
HRTX Q2 2018 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$153M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
+103.0% YoY
Gross Profit
$12M
69.7% margin
Operating Income
-$39M
-224.9% margin
Net Income
-$39M
-223.8% margin
EPS (Diluted)
$-0.54
QoQ Revenue Growth
+49.4%
Cash Flow
Operating Cash Flow
-$61M
Free Cash Flow
-$62M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$511M
Total Liabilities
$79M
Stockholders' Equity
$432M
Cash & Equivalents
$259M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$9M
+103.0%
Gross Profit
$12M
$7M
+60.7%
Operating Income
-$39M
-$42M
+7.6%
Net Income
-$39M
-$43M
+9.6%
← FY 2018
All Quarters
Q3 2018 →